Robeco Institutional Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $290M | Buy |
|
|||||
|
2025
Q2 | $246M | Buy |
|
|||||
|
2025
Q1 | $188M | Buy |
|
|||||
|
2024
Q4 | $169M | Buy |
|
|||||
|
2024
Q3 | $130M | Buy |
|
|||||
|
2024
Q2 | $57M | Sell |
|
|||||
|
2024
Q1 | $74.8M | Sell |
|
|||||
|
2023
Q4 | $102M | Sell |
|
|||||
|
2023
Q3 | $144M | Sell |
|
|||||
|
2023
Q2 | $194M | Sell |
|
|||||
|
2023
Q1 | $250M | Sell |
|
|||||
|
2022
Q4 | $320M | Sell |
|
|||||
|
2022
Q3 | $317M | Sell |
|
|||||
|
2022
Q2 | $400M | Sell |
|
|||||
|
2022
Q1 | $429M | Sell |
|
|||||
|
2021
Q4 | $501M | Sell |
|
|||||
|
2021
Q3 | $434M | Sell |
|
|||||
|
2021
Q2 | $405M | Buy |
|
|||||
|
2021
Q1 | $322M | Sell |
|
|||||
|
2020
Q4 | $339M | Sell |
|
|||||
|
2020
Q3 | $359M | Buy |
|
|||||
|
2020
Q2 | $235M | Sell |
|
|||||
|
2020
Q1 | $236M | Sell |
|
|||||
|
2019
Q4 | $284M | Buy |
|
|||||
|
2019
Q3 | $238M | Sell |
|
|||||
|
2019
Q2 | $315M | Sell |
|
|||||
|
2019
Q1 | $312M | Buy |
|
|||||
|
2018
Q4 | $315M | Sell |
|
|||||
|
2018
Q3 | $322M | Buy |
|
|||||
|
2018
Q2 | $257M | Buy |
|
|||||
|
2018
Q1 | $249M | Buy |
|
|||||
|
2017
Q4 | $145M | Buy |
|
|||||
|
2017
Q3 | $117M | Buy |
|
|||||
|
2017
Q2 | $109M | Sell |
|
|||||
|
2017
Q1 | $113M | Buy |
|
|||||
|
2016
Q4 | $104M | Buy |
|
|||||
|
2016
Q3 | $103M | Buy |
|
|||||
|
2016
Q2 | $77.2M | Buy |
|
|||||
|
2016
Q1 | $60M | Sell |
|
|||||
|
2015
Q4 | $69.5M | Sell |
|
|||||
|
2015
Q3 | $154M | Sell |
|
|||||
|
2015
Q2 | $196M | Sell |
|
|||||
|
2015
Q1 | $223M | Sell |
|
|||||
|
2014
Q4 | $219M | Sell |
|
|||||
|
2014
Q3 | $220M | Buy |
|
|||||
|
2014
Q2 | $217M | Sell |
|
|||||
|
2014
Q1 | $267M | Buy |
|
|||||
|
2013
Q4 | $238M | Buy |
|
|||||
|
2013
Q3 | $214M | Sell |
|
|||||
|
2013
Q2 | $214M | Buy |
|